| 2nd Sep 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 2nd Sep 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 2nd Sep 2021 7:00 am |
RNS |
CimetrA import approval granted in India |
| 1st Sep 2021 7:00 am |
RNS |
Preliminary Financial Report for 30 June 2021 |
| 31st Aug 2021 7:00 am |
RNS |
Proposed Issue of Securities and Appendix 3B |
| 27th Aug 2021 9:00 am |
RNS |
Holder Update - MXCOE Listed Options |
| 26th Aug 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 26th Aug 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 26th Aug 2021 7:10 am |
RNS |
MGC Pharma executes US$24m agreement with US firm |
| 12th Aug 2021 1:21 pm |
RNS |
Results of General Meeting |
| 6th Aug 2021 8:47 am |
RNS |
General Meeting Information and Webinar |
| 3rd Aug 2021 7:00 am |
RNS |
Expiry of Share Options |
| 26th Jul 2021 7:00 am |
RNS |
Quarterly Results |
| 16th Jul 2021 7:56 am |
RNS |
Amendment to Expiry of Share Options |
| 15th Jul 2021 7:17 am |
RNS |
Cannabinoid Patent Application Submitted |
| 13th Jul 2021 10:52 am |
RNS |
Expiry of Share Options |
| 13th Jul 2021 9:38 am |
RNS |
Issue of Shares and Cleansing Statement |
| 12th Jul 2021 7:00 am |
RNS |
Phase III CimetrA™ Clinical Trial Commences |
| 9th Jul 2021 9:16 am |
RNS |
Cleansing Notice and Appendix 2A |
| 9th Jul 2021 7:00 am |
RNS |
Notice of GM |
| 15th Jun 2021 7:00 am |
RNS |
CannEpil - Primary Care Reimbursement in Ireland |
| 9th Jun 2021 7:24 am |
RNS |
Appointment of Company Secretary |
| 25th May 2021 7:00 am |
RNS |
2021 Clinical Trials Program Update |
| 17th May 2021 7:58 am |
RNS |
CimetrA Patent Submitted to European IP Office |
| 14th May 2021 7:59 am |
RNS |
Appendix 3G |
| 14th May 2021 7:50 am |
RNS |
Appendix 2A - Issue of Shares |
| 7th May 2021 7:27 am |
RNS |
Research Update - ArtemiC |
| 6th May 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 6th May 2021 7:31 am |
RNS |
ASX Trading Halt |
| 4th May 2021 7:00 am |
RNS |
New ArtemiC Order Received From Swiss PharmaCan AG |
| 28th Apr 2021 7:00 am |
RNS |
Application to Health Canada for ArtemiC Approval |
| 27th Apr 2021 7:00 am |
RNS |
Quarterly Results |
| 22nd Apr 2021 7:00 am |
RNS |
Acquisition of MediCaNL |
| 21st Apr 2021 12:36 pm |
RNS |
Issue of Equity |
| 9th Apr 2021 7:00 am |
RNS |
Investor Presentation |
| 8th Apr 2021 11:00 am |
RNS |
Corporate Update |
| 7th Apr 2021 7:08 am |
RNS |
ArtemiC Rescue First Delivery and March Revenue |
| 31st Mar 2021 12:54 pm |
RNS |
GM Statement |
| 24th Mar 2021 9:03 am |
RNS |
Appendix 2A - Issue of Shares |
| 22nd Mar 2021 7:30 am |
RNS |
Phase III Clinical Trial of CimetrA Approved |
